Continuous Glucose Monitoring Explained: How CGM Works, What It Shows, and Who Needs It

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider to determine whether CGM is appropriate for your diabetes management plan.

Continuous glucose monitoring (CGM) has transformed how people with type 2 diabetes understand and manage their blood sugar. Rather than isolated snapshots from fingerstick testing, CGM provides a real-time, continuous view of glucose levels and trends — revealing how food, exercise, stress, sleep, and medications all affect blood sugar throughout the day and night.

What Is Continuous Glucose Monitoring (CGM)?

A CGM system measures glucose in the interstitial fluid (the fluid surrounding cells just below the skin surface) rather than directly in blood. It consists of three components:

• A small sensor inserted just under the skin (typically on the upper arm or abdomen) with a tiny filament that measures glucose electrochemically
• A transmitter attached to the sensor that wirelessly sends readings to a display device
• A receiver, smartphone app, or smartwatch that displays current glucose, trend arrows, and graphs of glucose over time

Most modern CGMs take a reading every 1–5 minutes, generating hundreds of data points per day. Trend arrows show whether glucose is stable, rising, or falling — and at what rate — allowing users to anticipate changes before they become problematic.

How Accurate Is CGM?

CGM measures interstitial glucose, which lags behind blood glucose by approximately 5–10 minutes. Modern systems have Mean Absolute Relative Difference (MARD) values of 8–10%, meaning readings are typically within 8–10% of a simultaneous fingerstick blood glucose. This accuracy is sufficient for treatment decisions for most people with type 2 diabetes on non-insulin therapies.

For people on intensive insulin regimens who are making rapid dosing decisions, some systems still require occasional fingerstick confirmation — particularly when symptoms don’t match the CGM reading, during rapid glucose changes, or when the sensor is newly placed.

What CGM Systems Are Available?

Over-the-counter CGM options (Stelo, Lingo) launched in 2024 have significantly expanded access for people with type 2 diabetes not on insulin, removing the prescription barrier entirely. For a detailed comparison of current CGM options, see our guide: Best CGM for Type 2 Diabetes.

What Is the Difference Between Real-Time CGM and Intermittently Scanned CGM?

• Real-time CGM (rtCGM): Automatically and continuously sends glucose readings to your device every few minutes. Provides immediate alerts for high and low blood sugar without any action on your part.
• Intermittently scanned CGM (isCGM): The sensor collects continuous data but only displays it when you hold your phone or reader near the sensor to scan it. The FreeStyle Libre 2 works this way (though newer Libre 3 is real-time). Alarms may still trigger for extreme values.

For people on insulin, real-time CGM with active alarms is generally preferred. For people managing type 2 diabetes with oral medications or lifestyle alone, isCGM or OTC devices are often sufficient and more affordable.

What Does CGM Tell You That a Glucometer Doesn’t?

A traditional glucometer gives you a blood sugar number at one moment in time. CGM reveals:

• Glucose trends: Is blood sugar rising fast, rising slowly, stable, falling slowly, or dropping quickly? A reading of 140 mg/dL with a rapidly rising arrow requires different action than 140 with a stable arrow.
• Time in Range (TIR): What percentage of time is spent within the target range (70–180 mg/dL)? This is now a recognized clinical metric alongside HbA1c.
• Post-meal patterns: How specific foods affect blood sugar — invaluable for making dietary adjustments
• Nocturnal patterns: What happens to blood sugar during sleep — catching nocturnal highs or lows that would otherwise go unnoticed
• Exercise effects: How different types of exercise raise, lower, or stabilize glucose
• Stress and illness impact: CGM makes the blood sugar effect of psychological and physical stress visible and measurable

What Is the Ambulatory Glucose Profile (AGP)?

The Ambulatory Glucose Profile is a standardized one-page report generated from CGM data. It overlays multiple days of glucose readings into a single 24-hour curve, showing the typical pattern plus the range of variability. Clinicians use AGP reports to adjust medications, identify problem periods, and set treatment goals. Most CGM apps generate this report automatically.

Who Should Use CGM for Type 2 Diabetes?

The ADA’s Standards of Care recommend CGM for:

• All people with type 2 diabetes on multiple daily insulin injections
• People with type 2 diabetes on basal insulin who experience hypoglycemia or have hypoglycemia unawareness
• People with type 2 diabetes on non-insulin therapy who want to use CGM to improve understanding and self-management (particularly useful for making food and activity choices)

Even for people not on insulin, short-term “blinded” CGM use (wearing a device for 1–2 weeks to learn patterns) can be highly educational. Research shows that even brief CGM use motivates significant dietary and lifestyle changes in people with type 2 diabetes who have never used insulin.

Is CGM Covered by Insurance?

Coverage has expanded significantly in recent years:

• Medicare: Covers therapeutic CGM for people with diabetes who take insulin or have a history of hypoglycemia (Part B). Coverage was expanded in 2023 to include more people with type 2 diabetes.
• Private insurance: Most major insurers cover CGM for people on insulin; coverage for non-insulin users varies by plan and requires documentation of medical necessity
• OTC options: Stelo and Lingo require no prescription and no insurance — available at retail pharmacies and online, typically $89–$99 for two sensors (one month’s supply)

According to the NIDDK, the landscape of CGM coverage continues to evolve rapidly — check with your insurer or pharmacist for current coverage details.

What Are the Limitations of CGM?

• Lag time: Interstitial glucose lags blood glucose by 5–10 minutes — may not capture the absolute peak of rapid blood sugar spikes
• Sensor failures: Occasional sensors read inaccurately and must be replaced
• Interfering substances: Acetaminophen (Tylenol) can cause falsely elevated readings on some systems (primarily older models)
• Skin reactions: Some users develop adhesive reactions or irritation at the sensor site
• Data overload: The volume of data generated can feel overwhelming without education on how to interpret and act on it
• Cost: Prescription CGMs can cost $300–$500 per month without insurance

Key Takeaways

• CGM provides continuous, real-time glucose data and trend information — far more actionable than isolated fingerstick readings
• Both prescription and over-the-counter CGM options are now available; OTC devices (Stelo, Lingo) have eliminated the prescription barrier for many users
• CGM is particularly valuable for identifying post-meal patterns, nocturnal glucose behavior, and the effects of food, exercise, and stress
• Time in Range (TIR) — the percentage of time in the 70–180 mg/dL range — is a clinically meaningful metric that CGM uniquely provides
• Even short-term CGM use without insulin has been shown to motivate meaningful behavior change in type 2 diabetes

Related Reading

• Best CGM for Type 2 Diabetes: A Comparison Guide
• What Is a Normal Blood Sugar Level?
• How to Lower Your A1C Level
• Daily Management Tips for Type 2 Diabetes
• Type 2 Diabetes Treatment Guidelines

keithsurveys2@gmail.com

Keith Williams is the creator of ABCs of A1C, an educational resource focused on blood sugar control and Type 2 diabetes awareness. His work focuses on translating complex metabolic and diabetes research into practical lifestyle information that readers can understand and apply in daily life.

See Full Bio